Fighting cancer can seem like a deadly game of chance. While some patients may respond well to certain treatments, others might not be as fortunate. Doctors and scientists have long struggled to explain why. Now scientists have found a possible source of this variability in clear cell renal cell carcinoma (ccRCC) -- the most common kidney cancer diagnosed in adults.
